Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

  • RnM3373213
    • |
  • 02 May, 2019
    • |
  • 85 Pages
    • |
  • Global Markets Direct
    • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$3,500.00
$7,000.00
$10,500.00
2,761.50
5,523.00
8,284.50
3,321.50
6,643.00
9,964.50
546,385.00
1,092,770.00
1,639,155.00
295,645.00
591,290.00
886,935.00
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo